Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization

To test the hypothesis that increased Rap1a activity specifically in retinal pigment epithelial cells resists choroidal neovascularization (CNV), self-complementary adeno-associated virus 2 (scAAV2) with RPE65-promoter-driven GFP vectors were generated and introduced subretinally into Rap1b-deficien...

Full description

Bibliographic Details
Main Authors: Haibo Wang, Xiaokun Han, Colin A Bretz, Silke Becker, Deeksha Gambhir, George W Smith, R Jude Samulski, Erika S Wittchen, Lawrence A Quilliam, Magdalena Chrzanowska-Wodnicka, M Elizabeth Hartnett
Format: Article
Language:English
Published: Elsevier 2016-01-01
Series:Molecular Therapy: Methods & Clinical Development
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050117300281
_version_ 1818193065007906816
author Haibo Wang
Xiaokun Han
Colin A Bretz
Silke Becker
Deeksha Gambhir
George W Smith
R Jude Samulski
Erika S Wittchen
Lawrence A Quilliam
Magdalena Chrzanowska-Wodnicka
M Elizabeth Hartnett
author_facet Haibo Wang
Xiaokun Han
Colin A Bretz
Silke Becker
Deeksha Gambhir
George W Smith
R Jude Samulski
Erika S Wittchen
Lawrence A Quilliam
Magdalena Chrzanowska-Wodnicka
M Elizabeth Hartnett
author_sort Haibo Wang
collection DOAJ
description To test the hypothesis that increased Rap1a activity specifically in retinal pigment epithelial cells resists choroidal neovascularization (CNV), self-complementary adeno-associated virus 2 (scAAV2) with RPE65-promoter-driven GFP vectors were generated and introduced subretinally into Rap1b-deficient mice. Six-week-old mice that received subretinal control (scAAV2-Con) or constitutively active Rap1a (scAAV2-CARap1a) showed strong GFP at the 5 × 108 viral particle/μl dose 5 weeks later without altering retinal morphology or function. Compared to scAAV2-Con- or phosphate-buffered saline (PBS)-injected, eyes injected with scAAV2-CARap1a had increased Rap1 in retinal pigment epithelial (RPE)/choroidal lysates and a significant reduction in CNV volume 7 days after laser, comparable to eyes that received intravitreal anti-VEGF versus IgG control. scAAV2-CARap1a-, but not anti-VEGF-, injected eyes had increased pan-cadherin in RPE/choroids. In cultured RPE cells, increased active Rap1a inhibited TNFα-induced disassociation of junctional pan-cadherin/β-catenin complexes, increased transepithelial electrical resistance through an interaction of β-catenin with phosphorylated scaffold protein, IQGAP1, and inhibited choroidal endothelial cell (CEC) transmigration of an RPE monolayer. This evidence shows that increased Rap1a activity specifically in RPE cells is sufficient to reduce CEC transmigration and CNV and involves IQGAP1-mediated protection of RPE junctional complexes.
first_indexed 2024-12-12T00:40:28Z
format Article
id doaj.art-cd8e2b0f679940ba84f1a0b4c6314f90
institution Directory Open Access Journal
issn 2329-0501
language English
last_indexed 2024-12-12T00:40:28Z
publishDate 2016-01-01
publisher Elsevier
record_format Article
series Molecular Therapy: Methods & Clinical Development
spelling doaj.art-cd8e2b0f679940ba84f1a0b4c6314f902022-12-22T00:44:16ZengElsevierMolecular Therapy: Methods & Clinical Development2329-05012016-01-013C10.1038/mtm.2016.56Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularizationHaibo Wang0Xiaokun Han1Colin A Bretz2Silke Becker3Deeksha Gambhir4George W Smith5R Jude Samulski6Erika S Wittchen7Lawrence A Quilliam8Magdalena Chrzanowska-Wodnicka9M Elizabeth Hartnett10The John Moran Eye Center, University of Utah, Salt Lake City, Utah, USAThe John Moran Eye Center, University of Utah, Salt Lake City, Utah, USAThe John Moran Eye Center, University of Utah, Salt Lake City, Utah, USAThe John Moran Eye Center, University of Utah, Salt Lake City, Utah, USAThe John Moran Eye Center, University of Utah, Salt Lake City, Utah, USAThe John Moran Eye Center, University of Utah, Salt Lake City, Utah, USAUNC Vector Core, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USADepartment of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USADepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USABlood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin, USAThe John Moran Eye Center, University of Utah, Salt Lake City, Utah, USATo test the hypothesis that increased Rap1a activity specifically in retinal pigment epithelial cells resists choroidal neovascularization (CNV), self-complementary adeno-associated virus 2 (scAAV2) with RPE65-promoter-driven GFP vectors were generated and introduced subretinally into Rap1b-deficient mice. Six-week-old mice that received subretinal control (scAAV2-Con) or constitutively active Rap1a (scAAV2-CARap1a) showed strong GFP at the 5 × 108 viral particle/μl dose 5 weeks later without altering retinal morphology or function. Compared to scAAV2-Con- or phosphate-buffered saline (PBS)-injected, eyes injected with scAAV2-CARap1a had increased Rap1 in retinal pigment epithelial (RPE)/choroidal lysates and a significant reduction in CNV volume 7 days after laser, comparable to eyes that received intravitreal anti-VEGF versus IgG control. scAAV2-CARap1a-, but not anti-VEGF-, injected eyes had increased pan-cadherin in RPE/choroids. In cultured RPE cells, increased active Rap1a inhibited TNFα-induced disassociation of junctional pan-cadherin/β-catenin complexes, increased transepithelial electrical resistance through an interaction of β-catenin with phosphorylated scaffold protein, IQGAP1, and inhibited choroidal endothelial cell (CEC) transmigration of an RPE monolayer. This evidence shows that increased Rap1a activity specifically in RPE cells is sufficient to reduce CEC transmigration and CNV and involves IQGAP1-mediated protection of RPE junctional complexes.http://www.sciencedirect.com/science/article/pii/S2329050117300281
spellingShingle Haibo Wang
Xiaokun Han
Colin A Bretz
Silke Becker
Deeksha Gambhir
George W Smith
R Jude Samulski
Erika S Wittchen
Lawrence A Quilliam
Magdalena Chrzanowska-Wodnicka
M Elizabeth Hartnett
Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
Molecular Therapy: Methods & Clinical Development
title Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
title_full Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
title_fullStr Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
title_full_unstemmed Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
title_short Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
title_sort retinal pigment epithelial cell expression of active rap 1a by scaav2 inhibits choroidal neovascularization
url http://www.sciencedirect.com/science/article/pii/S2329050117300281
work_keys_str_mv AT haibowang retinalpigmentepithelialcellexpressionofactiverap1abyscaav2inhibitschoroidalneovascularization
AT xiaokunhan retinalpigmentepithelialcellexpressionofactiverap1abyscaav2inhibitschoroidalneovascularization
AT colinabretz retinalpigmentepithelialcellexpressionofactiverap1abyscaav2inhibitschoroidalneovascularization
AT silkebecker retinalpigmentepithelialcellexpressionofactiverap1abyscaav2inhibitschoroidalneovascularization
AT deekshagambhir retinalpigmentepithelialcellexpressionofactiverap1abyscaav2inhibitschoroidalneovascularization
AT georgewsmith retinalpigmentepithelialcellexpressionofactiverap1abyscaav2inhibitschoroidalneovascularization
AT rjudesamulski retinalpigmentepithelialcellexpressionofactiverap1abyscaav2inhibitschoroidalneovascularization
AT erikaswittchen retinalpigmentepithelialcellexpressionofactiverap1abyscaav2inhibitschoroidalneovascularization
AT lawrenceaquilliam retinalpigmentepithelialcellexpressionofactiverap1abyscaav2inhibitschoroidalneovascularization
AT magdalenachrzanowskawodnicka retinalpigmentepithelialcellexpressionofactiverap1abyscaav2inhibitschoroidalneovascularization
AT melizabethhartnett retinalpigmentepithelialcellexpressionofactiverap1abyscaav2inhibitschoroidalneovascularization